BHIVA HIV/hepatitis B and HIV/hepatitis C co-infection guidelines (2003): posted to web for consultation

Guidelines for HIV and Hepatitis B and C coinfection are now posted to the BHIVA website in a first draft as part of a public consultation. Comments are now welcomed.

The authors introduce the process on the website:

“In an area that is rapidly changing such as this, it should come as no surprise that there was quite vigorous discussion between members of the guidelines committee as to what to advise. This was especially the case with regard to the treatment recommendations:

Should dual therapy with both lamivudine and tenofovir be recommended for all patients with HIV and hepatitis B as part of their antiretroviral regimen, or should we await the outcome of clinical trials?
Is pegylated interferon to be recommended for treatment of Hepatitis C in HIV-positive patients in all circumstances or should we await the outcome of the NICE recommendations?
Is there enough evidence to recommend pegylated interferon rather than standard interferon in patients with genotype 2 and 3, given that the price differential may influence funding from the commissioners?

Your comments will be greatly appreciated. Please give feedback on these two guidelines by e-mailing Gary.Brook@nwlh.nhs.uk or there will be a chance to discuss them at the BHIVA conference on the 26th of April 2003.”

Gary Brook and Janice Main on behalf of the BHIVA HIV/Hepatitis Guideline Committees.

http://www.bhiva.org/guidelines.htm

Draft HIV and Hepatitis B Co-infection Guidelines
A draft version of the above guidelines may be downloaded as pdf files.
http://www.bhiva.org/HBV.pdf

Draft HIV and Hepatitis C Co-infection Guidelines
A draft version of the above guidelines may be downloaded as pdf files.
http://www.bhiva.org/HCV.pdf

Links to other websites are current at date of posting but not maintained.